encorafenib
SpainDrugs containing this active substance
-
It is used in adults to treat melanoma or non-small cell lung cancer (NSCLC) when they have a specific mutation in the BRAF gene and the cancer has spread or cannot be surgically removed. It is also used to treat colorectal cancer in adults with the same mutation who have already received other cancer treatments.
Form: capsules, hard
Active substance Dosage encorafenib 50 mg Manufacturer: Pierre Fabre Medicament
-
It is used in adults to treat melanoma or non-small cell lung cancer (NSCLC) when they present a specific mutation in the BRAF gene and the cancer has spread or cannot be operated on. It is also used to treat colorectal cancer in adults with the same mutation who have already received other cancer treatments.
Form: capsules, hard
Active substance Dosage encorafenib Igual a 75 mg mg Manufacturer: Pierre Fabre Medicament